You are viewing: North America Long Read Sequencing Market analysis
Part of: Long Read Sequencing Market (Global)

The North America Long Read Sequencing Market was valued at $186.5 Million in 2024 and projected to reach to $779 Million by 2029, representing a compound annual growth rate of 33.1%. North America is positioned as the global leader in long read sequencing adoption, driven by substantial venture capital investments, government funding for genomic research, and strong demand from academic medical centers and pharmaceutical companies.

North America Long Read Sequencing Market (2024-2029) : Size and Share
logo-mobile
CAGR of
cagr-Chart
USD Million
MARKET SNAPSHOT
Market Size in USD 26.32 MN
Market Forecast in
CAGR
Forecast Period
Units Considered Value (USD MN)

North America Long Read Sequencing Market Trends and Insights

  • North America's dominance in this sector is driven by advanced healthcare infrastructure, substantial R&D investments, and early adoption of genomic technologies.
  • The region's leading pharmaceutical and biotechnology companies are increasingly integrating long read sequencing into drug discovery and precision medicine initiatives, positioning North America as a critical growth engine for the global market. North America's market growth is underpinned by rising demand for accurate genomic analysis in clinical diagnostics and research applications.
  • Throughout the 2024-2029 forecast period, North America is expected to maintain its leadership through continued innovation in sequencing platforms and expanding applications in oncology, rare disease diagnosis, and infectious disease monitoring.
  • The region's regulatory environment and reimbursement frameworks are becoming increasingly favorable, further accelerating adoption among healthcare providers and research institutions across North America..

Key Market Statistics

  • CAGR (2024-2029) 33.1% CAGR
  • Market Size, 2024 ~USD 186.5 Million
  • Forecast, 2029 ~USD 779 Million
  • Geography North America

North America Long Read Sequencing Market Overview

Market Valuation & Growth :

North America's long read sequencing market is valued at $186.5 million in 2024, with a robust CAGR of 33.1% projected to reach $779.0 million by 2029, significantly outpacing global growth at 32.8%.

US Market Dominance :

The United States commands the North American market with $740.4 million in 2024, representing approximately 79.7% of the regional market share and driving innovation across genomic research and clinical applications.

Advanced Healthcare Infrastructure :

North America benefits from world-class healthcare systems, extensive R&D funding, and early adoption of cutting-edge genomic technologies by leading pharmaceutical and biotechnology companies across the region.

Canadian Growth Opportunity :

Canada represents a secondary but growing market at $63.5 million in 2024, with increasing investments in genomic research centers and precision medicine initiatives supporting regional expansion.

North America Long Read Sequencing Market Dynamics

  • The region's sophisticated healthcare ecosystem and regulatory framework accelerate the integration of long read sequencing into clinical diagnostics and drug development pipelines. The forecast period through 2029 will witness accelerated market penetration as sequencing costs decline and clinical applications expand beyond research into routine diagnostics.
  • North American companies are establishing themselves as technology leaders, with increasing commercialization of long read platforms and growing partnerships between biotech firms and healthcare providers strengthening market dynamics..

Related Ecosystem

Biotechnology

Top Technologies
  • Reagents
  • Polymerase Chain Reaction (PCR)
  • Stem Cells
  • Assay Kits
  • Flow Cytometers
Top Companies
  • Thermo Fisher Scientific Inc.
  • Merck KGaA
  • Danaher Corporation
  • Agilent Technologies, Inc.
  • Bio-Rad Laboratories, Inc.

    Key Takeaways

    • North America's long read sequencing market will grow from $186.5M (2024) to $779.0M (2029), representing a 33.1% CAGR.
    • North America leads global adoption due to advanced healthcare infrastructure, robust R&D funding, and strong biotech ecosystem.
    • Clinical diagnostics and precision medicine applications are driving North America's market expansion through 2029.
    • North America's favorable regulatory environment and reimbursement policies accelerate technology adoption among healthcare institutions.

    Long Read Sequencing Market Report Scope

    Report Metric Details
    Base Year 2024
    Fastest Growing Segment DATA ANALYSIS (Workflow)
    Forecast Period 2024-2029
    Growth Rate CAGR of 32.8% from 2024 to 2029
    Largest Segment RESEARCH USAGE (Usage)
    Market Size Base Year (Billions) ~USD 0.76 (2024)
    Revenue Forecast (Billions) ~USD 3.13 (2029)
    Segments Covered Offering, Technology, Workflow, Application, Usage, End User

    North America Long Read Sequencing Market Report Segmentation

    6 segment dimensions are covered across the global market.

    By Offering

    • Consumables
    • Instruments
    • Services

    By Technology

    • Nanopore Sequencing
    • Single-Molecule Real-Time Sequencing
    • Synthetic Long-Read Sequencing

    By Workflow

    • Data Analysis
    • Sample Preparation
    • Sequencing

    By Application

    • Epigenetics
    • Metagenomics
    • Other Applications
    • Targeted Sequencing
    • Whole-Exome Sequencing
    • Whole-Genome Sequencing

    By Usage

    • Clinical Usage
    • Research Usage

    By End User

    • Academic & Research Institute
    • Academic & Research Institutes
    • Hospitals, Clinics & Diagnostic
    • Hospitals, Clinics, And Diagnostic Labs
    • Other End User
    • Other End Users
    • Pharmaceutical & Biotechnologies Companies
    • Pharmaceutical & Biotechnology Companies
    • Pharmaceutical & Biotechnology Companies Labs

    Target Audience

    • Biotechnology & Sequencing Companies : Evaluate North American market opportunities, competitive positioning, and expansion strategies to maximize market share in the fastest-growing genomic sequencing region globally.
    • Pharmaceutical & Healthcare Organizations : Understand long read sequencing adoption trends in North American clinical settings to inform drug development strategies, biomarker discovery, and precision medicine initiatives.
    • Healthcare Investors & Venture Capitalists : Identify high-growth investment opportunities in North American long read sequencing companies, emerging technologies, and clinical applications with strong market expansion potential.
    • Academic & Research Institutions : Access market data on funding availability, technology adoption rates, and collaborative opportunities within North America's genomic research ecosystem for strategic planning.
    • Healthcare Providers & Diagnostic Labs : Benchmark long read sequencing implementation strategies, understand clinical utility evidence, and evaluate technology partnerships to enhance diagnostic capabilities in North America.

    North America vs. other regions

    HowNorth America compares to the other 3 regional blocs covered in this market.

    Europe
    ~USD 526.3 Million · 33.7% wtd CAGR ·
    Asia Pacific
    ~USD 450.4 Million · 34.9% wtd CAGR ·
    Latin America
    ~USD 86.8 Million · 29.9% wtd CAGR ·
    Middle East
    ~USD 73.3 Million · 27.6% wtd CAGR ·

    Countries within North America - compare and drill down

    Country2025 size (native)
    USUSD 740.4 Million
    CanadaUSD 63.5 Million

    Country market size visualization

    US
    USD 740.4 Million
    Canada
    USD 63.5 Million

    Reasons to Buy this Report

    • Regional Market Segmentation : Gain detailed insights into US and Canadian market dynamics separately, understanding country-specific growth drivers, regulatory environments, and investment patterns within North America's long read sequencing ecosystem.
    • Competitive Landscape Analysis : Identify leading North American sequencing technology providers, their market positioning, and strategic initiatives to understand competitive advantages and partnership opportunities in the region.
    • Clinical Application Trends : Understand how North American healthcare providers are adopting long read sequencing for cancer genomics, rare disease diagnosis, and personalized medicine, with specific adoption rates and clinical outcomes data.
    • Investment & Funding Insights : Access comprehensive data on venture capital, government grants, and corporate R&D spending driving North American long read sequencing innovation and commercialization strategies.
    • Market Entry Strategy : Develop targeted go-to-market strategies for North America with region-specific recommendations on pricing, distribution channels, regulatory pathways, and key opinion leader engagement.

    Frequently asked questions

    What is the projected market size for long read sequencing in North America by 2029?

    North America's long read sequencing market is projected to reach $779.0 million by 2029, growing from $186.5 million in 2024.

    What is the CAGR for North America's long read sequencing market?

    North America's long read sequencing market is expected to grow at a compound annual growth rate (CAGR) of 33.1% from 2024 to 2029.

    Why is North America a leading market for long read sequencing technology?

    North America leads due to its advanced healthcare infrastructure, significant R&D investments, strong biotechnology sector, and early adoption of genomic innovations.

    What are the primary applications driving growth in North America's long read sequencing market?

    Key applications include clinical diagnostics, precision medicine, oncology research, rare disease diagnosis, and infectious disease monitoring across North America.

    How do regulatory and reimbursement factors impact North America's long read sequencing market?

    North America's favorable regulatory environment and improving reimbursement frameworks are accelerating technology adoption among healthcare providers and research institutions.

    RESEARCH METHODOLOGY

    This study on the long-read sequencing market employed secondary sources, directories, and databases to gather pertinent information. To gather and validate important qualitative and quantitative data and evaluate market growth prospects, in-depth interviews were conducted with many primary respondents including key industry participants, subject-matter experts (SMEs), C-level executives from key market players, and industry consultants. After estimating the long-read sequencing market using several research strategies, the size of the final market was obtained by triangulating data from primary research.

    Secondary Research

    The secondary sources referred to for this research study include publications from government sources. These include Nucleic Acids Research, Genome Biology, Nature Reviews Genetics, Nature Methods, Genome Research, International Journal of Genomics, National Human Genome Research Institute (NHGRI), International Chromosome and Genome Society (ICGS), Genome Canada, European Society of Human Genetics (ESHG), Genomics England, Genome British Columbia, Beijing Institute of Genomics, Centre for Cellular & Molecular Biology (CCMB), São Paulo Research Foundation (FAPESP), National Cancer Institute (NCI), European Medicines Agency (EMA), Biotechnology and Biological Sciences Research Council (BBSRC), Organisation for Economic Co-operation and Development (OECD), Population Health Research Institute (PHRI),  PubMed, World Bank, and the World Health Organization (WHO), among others. Secondary sources also included corporate & regulatory filings, such as annual reports, SEC filings, investor presentations, and financial statements; business magazines & research journals; press releases; and trade, business, and professional associations. Secondary data was collected and analyzed to arrive at the overall size of the global long-read sequencing market, which was validated through primary research.

    Primary Research

    Extensive primary research was conducted after acquiring basic knowledge about the global long-read sequencing market scenario through secondary research. Several primary interviews were conducted with market experts from the supply side, such as C-level and D-level executives, operational managers, marketing & sales managers of key manufacturers, distributors, and channel partners of companies providing long-read sequencing; experts from the demand side, such as personnel from academic & research institutes, hospitals, clinics and diagnostic labs, pharmaceutical & biopharmaceutical industries. These interviews were conducted across six major regions, including North America, Europe, the Asia Pacific, Latin America, the Middle East, and Africa. Approximately 70% and 30% of the primary interviews were conducted with supply-side and demand-side participants, respectively. This primary data was collected through questionnaires, e-mails, online surveys, personal interviews, and telephonic interviews.

    The following is a breakdown of the primary respondents:

    Long Read Sequencing Market Size, and Share

    To know about the assumptions considered for the study, download the pdf brochure

    Market Size Estimation

    Both top-down and bottom-up approaches were used to estimate and validate the total size of the long-read sequencing market. These methods were also used extensively to estimate the size of various subsegments in the market. The research methodology used to estimate the market size includes the following:

    Bottom-up Approach

    • The key players in the industry and market have been identified through extensive secondary research.
    • The revenues generated from the long-read sequencing market business of leading players have been determined through primary and secondary research.
    • All percentage shares, splits, and breakdowns have been determined using secondary sources and verified through primary sources.

    Long Read Sequencing Market Size, and Share

    To know about the assumptions considered for the study, Request for Free Sample Report

    Top-down Approach

    After arriving at the overall market size from the market size estimation process, the total market was split into several segments and subsegments.

    Long Read Sequencing Market Size, and Share

    Data Triangulation

    To complete the overall market engineering process and arrive at the exact statistics for all segments and subsegments, data triangulation and market breakdown procedures were employed, wherever applicable. The data was triangulated by studying various factors and trends from both the demand and supply sides.

    Market Definition

    Long-read sequencing is a type of nucleic acid sequencing that produces genomic data by generating individual reads from single molecules, generally ranging in size from 700 to over 20,000 bases. These fragments are typically derived from "native" molecules, which are directly extracted from biological samples for analysis. The long-read sequencing market encompasses the consumables, instruments, services, and technology associated with long-read sequencing. The long-read sequencing market is defined as solutions including instruments/systems, consumables (kits, reagents, flow cells), and services for long-read sample preparation, sequencing, and data analysis. Long-read software solutions are often provided alongside the instrument/system/platform, hence the software solutions are considered within the instrument segment scope. Other standalone software solutions are provided as data analysis services and are considered within the services segment scope.

    Stakeholders

    • Academic & Research Institutes
    • Software & Bioinformatics Companies
    • Healthcare & Clinical Laboratories
    • Long-Read Sequencing Technology Vendors
    • Contract Research Organizations (CROs)
    • Market Research and Consulting Firms
    • Pharmaceutical & Biotechnology Companies
    • Regulatory Agencies
    • Venture Capitalists
    • Government Organizations
    • Industry Associations and Professional Societies

    Report Objectives

    • To define, describe, and forecast the long-read sequencing market based on offerings, technology, workflow, application, usage, end user, and region
    • To provide detailed information regarding the major factors influencing the market growth (such as drivers, restraints, opportunities, and challenges)
    • To strategically analyze micromarkets with respect to individual growth trends, prospects, and contributions to the overall long-read sequencing market
    • To analyze the opportunities in the market for stakeholders and provide details of the competitive landscape for market leaders
    • To forecast the size of the market segments with respect to six main regions, namely, North America, Europe, the Asia Pacific, Latin America, the Middle East, and Africa
    • To profile the key players in the global long-read sequencing market and comprehensively analyze their instruments, consumables, and services portfolios, market positions, and core competencies
    • To track and analyze competitive developments such as product & service launches, expansions, agreements, and collaborations in the long-read sequencing market
    • To benchmark players within the long-read sequencing market using the ‘Company Evaluation Matrix' framework, which analyzes market players based on various parameters within the broad categories of business and service strategy

    Available Customizations

    With the given market data, MarketsandMarkets offers customizations as per the company’s specific needs. The following customization options are available for the report:

    Geographical Analysis

    • Further breakdown of the Rest of Europe Long-Read Sequencing Market, by country
    • Further breakdown of the Rest of Asia Pacific Long-Read Sequencing Market, by country
    • Further breakdown of the Rest of Latin America Long-Read Sequencing Market, by country
    • Further breakdown of the Rest of Middle East Long-Read Sequencing Market, by country

    Company Information

    • Detailed analysis and profiling of additional market players (up to five)

    Segment Analysis

    • Further breakdown of the other application and other end users area into subsegments
    • Cross-segment analysis

    Get the Full Long Read Sequencing Market Report

    Full forecast, segment splits, and company analysis for all Long Read Sequencing Market.

    Need a Tailored Report?

    Customize this report to your needs

    Get 10% FREE Customization

    Customize This Report
    Fact checked
    DMCA.com Protection Status